nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—SLC22A4—rheumatoid arthritis	0.711	1	CbGaD
Procainamide—Sunitinib—IRAK1—rheumatoid arthritis	0.00211	0.374	CrCbGaD
Procainamide—Sunitinib—TYK2—rheumatoid arthritis	0.00121	0.215	CrCbGaD
Procainamide—Sunitinib—BLK—rheumatoid arthritis	0.00114	0.202	CrCbGaD
Procainamide—Aminohippurate—SLC22A4—rheumatoid arthritis	0.00098	0.173	CrCbGaD
Procainamide—DNMT1—Budesonide—Hydrocortisone—rheumatoid arthritis	0.000382	0.0763	CbGdCrCtD
Procainamide—DNMT1—Budesonide—Methylprednisolone—rheumatoid arthritis	0.00036	0.0719	CbGdCrCtD
Procainamide—DNMT1—Budesonide—Betamethasone—rheumatoid arthritis	0.000354	0.0708	CbGdCrCtD
Procainamide—DNMT1—Budesonide—Dexamethasone—rheumatoid arthritis	0.000354	0.0708	CbGdCrCtD
Procainamide—Flushing—Cyclosporine—rheumatoid arthritis	0.000352	0.00178	CcSEcCtD
Procainamide—Bradycardia—Prednisolone—rheumatoid arthritis	0.000351	0.00177	CcSEcCtD
Procainamide—DNMT1—Budesonide—Triamcinolone—rheumatoid arthritis	0.000346	0.0692	CbGdCrCtD
Procainamide—Hypotension—Azathioprine—rheumatoid arthritis	0.000346	0.00174	CcSEcCtD
Procainamide—Cardiac arrest—Prednisone—rheumatoid arthritis	0.000345	0.00174	CcSEcCtD
Procainamide—Bradycardia—Hydrocortisone—rheumatoid arthritis	0.000343	0.00173	CcSEcCtD
Procainamide—Thrombocytopenia—Leflunomide—rheumatoid arthritis	0.000342	0.00172	CcSEcCtD
Procainamide—Chills—Cyclosporine—rheumatoid arthritis	0.00034	0.00172	CcSEcCtD
Procainamide—Hepatic failure—Methotrexate—rheumatoid arthritis	0.000337	0.0017	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Azathioprine—rheumatoid arthritis	0.000337	0.0017	CcSEcCtD
Procainamide—Hallucination—Hydrocortisone—rheumatoid arthritis	0.000335	0.00169	CcSEcCtD
Procainamide—Anorexia—Leflunomide—rheumatoid arthritis	0.000333	0.00168	CcSEcCtD
Procainamide—DNMT1—Budesonide—Prednisone—rheumatoid arthritis	0.000329	0.0657	CbGdCrCtD
Procainamide—Hypotension—Leflunomide—rheumatoid arthritis	0.000326	0.00165	CcSEcCtD
Procainamide—Dysgeusia—Cyclosporine—rheumatoid arthritis	0.000323	0.00163	CcSEcCtD
Procainamide—Bradycardia—Triamcinolone—rheumatoid arthritis	0.000323	0.00163	CcSEcCtD
Procainamide—Bradycardia—Methylprednisolone—rheumatoid arthritis	0.000322	0.00163	CcSEcCtD
Procainamide—DNMT1—Budesonide—Prednisolone—rheumatoid arthritis	0.000321	0.0641	CbGdCrCtD
Procainamide—Musculoskeletal discomfort—Leflunomide—rheumatoid arthritis	0.000318	0.0016	CcSEcCtD
Procainamide—Hallucination—Methylprednisolone—rheumatoid arthritis	0.000315	0.00159	CcSEcCtD
Procainamide—Lethargy—Methotrexate—rheumatoid arthritis	0.000309	0.00156	CcSEcCtD
Procainamide—Ill-defined disorder—Cyclosporine—rheumatoid arthritis	0.000306	0.00154	CcSEcCtD
Procainamide—Feeling abnormal—Azathioprine—rheumatoid arthritis	0.000305	0.00154	CcSEcCtD
Procainamide—Decreased appetite—Leflunomide—rheumatoid arthritis	0.000304	0.00153	CcSEcCtD
Procainamide—Gastrointestinal pain—Azathioprine—rheumatoid arthritis	0.000302	0.00152	CcSEcCtD
Procainamide—Angioedema—Cyclosporine—rheumatoid arthritis	0.000302	0.00152	CcSEcCtD
Procainamide—Malaise—Cyclosporine—rheumatoid arthritis	0.000298	0.0015	CcSEcCtD
Procainamide—Cardiac disorder—Methylprednisolone—rheumatoid arthritis	0.000294	0.00148	CcSEcCtD
Procainamide—Bradycardia—Betamethasone—rheumatoid arthritis	0.000293	0.00148	CcSEcCtD
Procainamide—Bradycardia—Dexamethasone—rheumatoid arthritis	0.000293	0.00148	CcSEcCtD
Procainamide—Neutropenia—Prednisone—rheumatoid arthritis	0.000293	0.00148	CcSEcCtD
Procainamide—Abdominal pain—Azathioprine—rheumatoid arthritis	0.000292	0.00147	CcSEcCtD
Procainamide—Body temperature increased—Azathioprine—rheumatoid arthritis	0.000292	0.00147	CcSEcCtD
Procainamide—Feeling abnormal—Leflunomide—rheumatoid arthritis	0.000288	0.00145	CcSEcCtD
Procainamide—Hallucination—Dexamethasone—rheumatoid arthritis	0.000287	0.00144	CcSEcCtD
Procainamide—Hallucination—Betamethasone—rheumatoid arthritis	0.000287	0.00144	CcSEcCtD
Procainamide—Convulsion—Cyclosporine—rheumatoid arthritis	0.000286	0.00144	CcSEcCtD
Procainamide—Gastrointestinal pain—Leflunomide—rheumatoid arthritis	0.000286	0.00144	CcSEcCtD
Procainamide—Myalgia—Cyclosporine—rheumatoid arthritis	0.000281	0.00142	CcSEcCtD
Procainamide—Arthralgia—Cyclosporine—rheumatoid arthritis	0.000281	0.00142	CcSEcCtD
Procainamide—Ill-defined disorder—Prednisolone—rheumatoid arthritis	0.000279	0.00141	CcSEcCtD
Procainamide—Depression—Prednisone—rheumatoid arthritis	0.000279	0.0014	CcSEcCtD
Procainamide—Discomfort—Cyclosporine—rheumatoid arthritis	0.000278	0.0014	CcSEcCtD
Procainamide—Urticaria—Leflunomide—rheumatoid arthritis	0.000277	0.0014	CcSEcCtD
Procainamide—Abdominal pain—Leflunomide—rheumatoid arthritis	0.000276	0.00139	CcSEcCtD
Procainamide—Body temperature increased—Leflunomide—rheumatoid arthritis	0.000276	0.00139	CcSEcCtD
Procainamide—Angioedema—Prednisolone—rheumatoid arthritis	0.000275	0.00138	CcSEcCtD
Procainamide—Hypersensitivity—Azathioprine—rheumatoid arthritis	0.000272	0.00137	CcSEcCtD
Procainamide—Ill-defined disorder—Hydrocortisone—rheumatoid arthritis	0.000272	0.00137	CcSEcCtD
Procainamide—Confusional state—Cyclosporine—rheumatoid arthritis	0.000272	0.00137	CcSEcCtD
Procainamide—Malaise—Prednisolone—rheumatoid arthritis	0.000271	0.00137	CcSEcCtD
Procainamide—Dysgeusia—Triamcinolone—rheumatoid arthritis	0.000271	0.00136	CcSEcCtD
Procainamide—Angioedema—Hydrocortisone—rheumatoid arthritis	0.000268	0.00135	CcSEcCtD
Procainamide—Malaise—Hydrocortisone—rheumatoid arthritis	0.000265	0.00133	CcSEcCtD
Procainamide—Thrombocytopenia—Cyclosporine—rheumatoid arthritis	0.000264	0.00133	CcSEcCtD
Procainamide—Convulsion—Prednisolone—rheumatoid arthritis	0.00026	0.00131	CcSEcCtD
Procainamide—Eosinophilia—Methotrexate—rheumatoid arthritis	0.000259	0.00131	CcSEcCtD
Procainamide—Hypersensitivity—Leflunomide—rheumatoid arthritis	0.000257	0.0013	CcSEcCtD
Procainamide—Anorexia—Cyclosporine—rheumatoid arthritis	0.000257	0.0013	CcSEcCtD
Procainamide—Ill-defined disorder—Triamcinolone—rheumatoid arthritis	0.000256	0.00129	CcSEcCtD
Procainamide—Ill-defined disorder—Methylprednisolone—rheumatoid arthritis	0.000256	0.00129	CcSEcCtD
Procainamide—Bradycardia—Prednisone—rheumatoid arthritis	0.000255	0.00129	CcSEcCtD
Procainamide—Convulsion—Hydrocortisone—rheumatoid arthritis	0.000254	0.00128	CcSEcCtD
Procainamide—Diarrhoea—Azathioprine—rheumatoid arthritis	0.000253	0.00128	CcSEcCtD
Procainamide—Discomfort—Prednisolone—rheumatoid arthritis	0.000253	0.00127	CcSEcCtD
Procainamide—Angioedema—Triamcinolone—rheumatoid arthritis	0.000253	0.00127	CcSEcCtD
Procainamide—Angioedema—Methylprednisolone—rheumatoid arthritis	0.000252	0.00127	CcSEcCtD
Procainamide—Abdominal discomfort—Methotrexate—rheumatoid arthritis	0.000251	0.00127	CcSEcCtD
Procainamide—Asthenia—Leflunomide—rheumatoid arthritis	0.000251	0.00126	CcSEcCtD
Procainamide—Myalgia—Hydrocortisone—rheumatoid arthritis	0.00025	0.00126	CcSEcCtD
Procainamide—Hallucination—Prednisone—rheumatoid arthritis	0.00025	0.00126	CcSEcCtD
Procainamide—Malaise—Triamcinolone—rheumatoid arthritis	0.000249	0.00126	CcSEcCtD
Procainamide—Malaise—Methylprednisolone—rheumatoid arthritis	0.000249	0.00125	CcSEcCtD
Procainamide—Pruritus—Leflunomide—rheumatoid arthritis	0.000247	0.00125	CcSEcCtD
Procainamide—Discomfort—Hydrocortisone—rheumatoid arthritis	0.000247	0.00124	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Cyclosporine—rheumatoid arthritis	0.000246	0.00124	CcSEcCtD
Procainamide—Neutropenia—Methotrexate—rheumatoid arthritis	0.000245	0.00123	CcSEcCtD
Procainamide—Dizziness—Azathioprine—rheumatoid arthritis	0.000245	0.00123	CcSEcCtD
Procainamide—Shock—Prednisolone—rheumatoid arthritis	0.000241	0.00122	CcSEcCtD
Procainamide—Convulsion—Triamcinolone—rheumatoid arthritis	0.000239	0.00121	CcSEcCtD
Procainamide—Diarrhoea—Leflunomide—rheumatoid arthritis	0.000239	0.0012	CcSEcCtD
Procainamide—Convulsion—Methylprednisolone—rheumatoid arthritis	0.000239	0.0012	CcSEcCtD
Procainamide—Shock—Hydrocortisone—rheumatoid arthritis	0.000236	0.00119	CcSEcCtD
Procainamide—Myalgia—Triamcinolone—rheumatoid arthritis	0.000235	0.00119	CcSEcCtD
Procainamide—Vomiting—Azathioprine—rheumatoid arthritis	0.000235	0.00119	CcSEcCtD
Procainamide—Myalgia—Methylprednisolone—rheumatoid arthritis	0.000235	0.00118	CcSEcCtD
Procainamide—Arthralgia—Methylprednisolone—rheumatoid arthritis	0.000235	0.00118	CcSEcCtD
Procainamide—Decreased appetite—Cyclosporine—rheumatoid arthritis	0.000234	0.00118	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Hydrocortisone—rheumatoid arthritis	0.000233	0.0466	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Hydrocortisone—rheumatoid arthritis	0.000233	0.0466	CbGdCrCtD
Procainamide—Depression—Methotrexate—rheumatoid arthritis	0.000233	0.00117	CcSEcCtD
Procainamide—Flushing—Prednisone—rheumatoid arthritis	0.000233	0.00117	CcSEcCtD
Procainamide—Ill-defined disorder—Betamethasone—rheumatoid arthritis	0.000233	0.00117	CcSEcCtD
Procainamide—Ill-defined disorder—Dexamethasone—rheumatoid arthritis	0.000233	0.00117	CcSEcCtD
Procainamide—Discomfort—Triamcinolone—rheumatoid arthritis	0.000232	0.00117	CcSEcCtD
Procainamide—Discomfort—Methylprednisolone—rheumatoid arthritis	0.000232	0.00117	CcSEcCtD
Procainamide—Dizziness—Leflunomide—rheumatoid arthritis	0.000231	0.00116	CcSEcCtD
Procainamide—Renal failure—Methotrexate—rheumatoid arthritis	0.00023	0.00116	CcSEcCtD
Procainamide—Angioedema—Betamethasone—rheumatoid arthritis	0.000229	0.00116	CcSEcCtD
Procainamide—Angioedema—Dexamethasone—rheumatoid arthritis	0.000229	0.00116	CcSEcCtD
Procainamide—Anorexia—Hydrocortisone—rheumatoid arthritis	0.000228	0.00115	CcSEcCtD
Procainamide—Confusional state—Methylprednisolone—rheumatoid arthritis	0.000227	0.00114	CcSEcCtD
Procainamide—Malaise—Betamethasone—rheumatoid arthritis	0.000226	0.00114	CcSEcCtD
Procainamide—Malaise—Dexamethasone—rheumatoid arthritis	0.000226	0.00114	CcSEcCtD
Procainamide—Hypotension—Hydrocortisone—rheumatoid arthritis	0.000224	0.00113	CcSEcCtD
Procainamide—Feeling abnormal—Cyclosporine—rheumatoid arthritis	0.000222	0.00112	CcSEcCtD
Procainamide—Vomiting—Leflunomide—rheumatoid arthritis	0.000222	0.00112	CcSEcCtD
Procainamide—Shock—Triamcinolone—rheumatoid arthritis	0.000222	0.00112	CcSEcCtD
Procainamide—Shock—Methylprednisolone—rheumatoid arthritis	0.000221	0.00112	CcSEcCtD
Procainamide—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	0.00022	0.00111	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Methylprednisolone—rheumatoid arthritis	0.00022	0.044	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Methylprednisolone—rheumatoid arthritis	0.00022	0.044	CbGdCrCtD
Procainamide—Nausea—Azathioprine—rheumatoid arthritis	0.00022	0.00111	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.000218	0.0011	CcSEcCtD
Procainamide—Agranulocytosis—Methotrexate—rheumatoid arthritis	0.000218	0.0011	CcSEcCtD
Procainamide—Convulsion—Betamethasone—rheumatoid arthritis	0.000217	0.0011	CcSEcCtD
Procainamide—Convulsion—Dexamethasone—rheumatoid arthritis	0.000217	0.0011	CcSEcCtD
Procainamide—DNMT1—Betamethasone—Dexamethasone—rheumatoid arthritis	0.000217	0.0433	CbGdCrCtD
Procainamide—DNMT1—Dexamethasone—Betamethasone—rheumatoid arthritis	0.000217	0.0433	CbGdCrCtD
Procainamide—Urticaria—Cyclosporine—rheumatoid arthritis	0.000214	0.00108	CcSEcCtD
Procainamide—Myalgia—Dexamethasone—rheumatoid arthritis	0.000213	0.00108	CcSEcCtD
Procainamide—Myalgia—Betamethasone—rheumatoid arthritis	0.000213	0.00108	CcSEcCtD
Procainamide—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.000213	0.00107	CcSEcCtD
Procainamide—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.000213	0.00107	CcSEcCtD
Procainamide—DNMT1—Betamethasone—Triamcinolone—rheumatoid arthritis	0.000212	0.0423	CbGdCrCtD
Procainamide—DNMT1—Dexamethasone—Triamcinolone—rheumatoid arthritis	0.000212	0.0423	CbGdCrCtD
Procainamide—Discomfort—Dexamethasone—rheumatoid arthritis	0.000211	0.00106	CcSEcCtD
Procainamide—Discomfort—Betamethasone—rheumatoid arthritis	0.000211	0.00106	CcSEcCtD
Procainamide—Hypotension—Methylprednisolone—rheumatoid arthritis	0.00021	0.00106	CcSEcCtD
Procainamide—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000208	0.00105	CcSEcCtD
Procainamide—Nausea—Leflunomide—rheumatoid arthritis	0.000207	0.00105	CcSEcCtD
Procainamide—Probenecid—ALB—rheumatoid arthritis	0.000207	0.0366	CrCbGaD
Procainamide—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000205	0.00104	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000205	0.00103	CcSEcCtD
Procainamide—Ill-defined disorder—Prednisone—rheumatoid arthritis	0.000203	0.00102	CcSEcCtD
Procainamide—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000202	0.00102	CcSEcCtD
Procainamide—Shock—Dexamethasone—rheumatoid arthritis	0.000201	0.00102	CcSEcCtD
Procainamide—Shock—Betamethasone—rheumatoid arthritis	0.000201	0.00102	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Prednisone—rheumatoid arthritis	0.000201	0.0402	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Prednisone—rheumatoid arthritis	0.000201	0.0402	CbGdCrCtD
Procainamide—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.0002	0.00101	CcSEcCtD
Procainamide—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.0002	0.00101	CcSEcCtD
Procainamide—Angioedema—Prednisone—rheumatoid arthritis	0.0002	0.00101	CcSEcCtD
Procainamide—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000199	0.001	CcSEcCtD
Procainamide—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000197	0.000995	CcSEcCtD
Procainamide—Malaise—Prednisone—rheumatoid arthritis	0.000197	0.000993	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Prednisolone—rheumatoid arthritis	0.000196	0.0392	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Prednisolone—rheumatoid arthritis	0.000196	0.0392	CbGdCrCtD
Procainamide—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000196	0.000987	CcSEcCtD
Procainamide—Anorexia—Dexamethasone—rheumatoid arthritis	0.000195	0.000983	CcSEcCtD
Procainamide—Anorexia—Betamethasone—rheumatoid arthritis	0.000195	0.000983	CcSEcCtD
Procainamide—Urticaria—Prednisolone—rheumatoid arthritis	0.000195	0.000982	CcSEcCtD
Procainamide—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000195	0.000981	CcSEcCtD
Procainamide—Asthenia—Cyclosporine—rheumatoid arthritis	0.000193	0.000975	CcSEcCtD
Procainamide—Hypotension—Betamethasone—rheumatoid arthritis	0.000191	0.000964	CcSEcCtD
Procainamide—Hypotension—Dexamethasone—rheumatoid arthritis	0.000191	0.000964	CcSEcCtD
Procainamide—Pruritus—Cyclosporine—rheumatoid arthritis	0.000191	0.000961	CcSEcCtD
Procainamide—Urticaria—Hydrocortisone—rheumatoid arthritis	0.00019	0.000959	CcSEcCtD
Procainamide—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000189	0.000955	CcSEcCtD
Procainamide—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000189	0.000955	CcSEcCtD
Procainamide—Convulsion—Prednisone—rheumatoid arthritis	0.000189	0.000954	CcSEcCtD
Procainamide—Chills—Methotrexate—rheumatoid arthritis	0.000188	0.000948	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000186	0.00094	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000186	0.00094	CcSEcCtD
Procainamide—Arthralgia—Prednisone—rheumatoid arthritis	0.000186	0.000937	CcSEcCtD
Procainamide—Myalgia—Prednisone—rheumatoid arthritis	0.000186	0.000937	CcSEcCtD
Procainamide—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000186	0.000937	CcSEcCtD
Procainamide—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000185	0.000935	CcSEcCtD
Procainamide—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000184	0.00093	CcSEcCtD
Procainamide—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000184	0.000928	CcSEcCtD
Procainamide—Discomfort—Prednisone—rheumatoid arthritis	0.000184	0.000926	CcSEcCtD
Procainamide—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000181	0.000911	CcSEcCtD
Procainamide—Urticaria—Triamcinolone—rheumatoid arthritis	0.000179	0.000903	CcSEcCtD
Procainamide—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000179	0.000901	CcSEcCtD
Procainamide—Dysgeusia—Methotrexate—rheumatoid arthritis	0.000179	0.000901	CcSEcCtD
Procainamide—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.000178	0.000899	CcSEcCtD
Procainamide—Dizziness—Cyclosporine—rheumatoid arthritis	0.000178	0.000899	CcSEcCtD
Procainamide—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000178	0.000897	CcSEcCtD
Procainamide—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.000178	0.000897	CcSEcCtD
Procainamide—Decreased appetite—Betamethasone—rheumatoid arthritis	0.000178	0.000897	CcSEcCtD
Procainamide—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000176	0.00089	CcSEcCtD
Procainamide—Shock—Prednisone—rheumatoid arthritis	0.000175	0.000884	CcSEcCtD
Procainamide—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000172	0.000866	CcSEcCtD
Procainamide—Vomiting—Cyclosporine—rheumatoid arthritis	0.000171	0.000864	CcSEcCtD
Procainamide—Anorexia—Prednisone—rheumatoid arthritis	0.00017	0.000856	CcSEcCtD
Procainamide—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000169	0.000854	CcSEcCtD
Procainamide—Ill-defined disorder—Methotrexate—rheumatoid arthritis	0.000169	0.000854	CcSEcCtD
Procainamide—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.000169	0.00085	CcSEcCtD
Procainamide—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.000169	0.00085	CcSEcCtD
Procainamide—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000167	0.000844	CcSEcCtD
Procainamide—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000167	0.000844	CcSEcCtD
Procainamide—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000166	0.000838	CcSEcCtD
Procainamide—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000166	0.000836	CcSEcCtD
Procainamide—Malaise—Methotrexate—rheumatoid arthritis	0.000165	0.00083	CcSEcCtD
Procainamide—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000164	0.000826	CcSEcCtD
Procainamide—Urticaria—Betamethasone—rheumatoid arthritis	0.000163	0.00082	CcSEcCtD
Procainamide—Urticaria—Dexamethasone—rheumatoid arthritis	0.000163	0.00082	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	0.000162	0.000819	CcSEcCtD
Procainamide—Dizziness—Prednisolone—rheumatoid arthritis	0.000162	0.000818	CcSEcCtD
Procainamide—Asthenia—Triamcinolone—rheumatoid arthritis	0.000162	0.000816	CcSEcCtD
Procainamide—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.000162	0.000816	CcSEcCtD
Procainamide—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.000162	0.000816	CcSEcCtD
Procainamide—Abdominal pain—Betamethasone—rheumatoid arthritis	0.000162	0.000816	CcSEcCtD
Procainamide—Body temperature increased—Betamethasone—rheumatoid arthritis	0.000162	0.000816	CcSEcCtD
Procainamide—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000161	0.000814	CcSEcCtD
Procainamide—Nausea—Cyclosporine—rheumatoid arthritis	0.00016	0.000807	CcSEcCtD
Procainamide—Pruritus—Triamcinolone—rheumatoid arthritis	0.00016	0.000804	CcSEcCtD
Procainamide—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000159	0.000803	CcSEcCtD
Procainamide—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000158	0.000799	CcSEcCtD
Procainamide—Convulsion—Methotrexate—rheumatoid arthritis	0.000158	0.000797	CcSEcCtD
Procainamide—Arthralgia—Methotrexate—rheumatoid arthritis	0.000155	0.000783	CcSEcCtD
Procainamide—Myalgia—Methotrexate—rheumatoid arthritis	0.000155	0.000783	CcSEcCtD
Procainamide—Decreased appetite—Prednisone—rheumatoid arthritis	0.000155	0.000781	CcSEcCtD
Procainamide—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000154	0.000776	CcSEcCtD
Procainamide—Discomfort—Methotrexate—rheumatoid arthritis	0.000154	0.000774	CcSEcCtD
Procainamide—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000152	0.000768	CcSEcCtD
Procainamide—Confusional state—Methotrexate—rheumatoid arthritis	0.00015	0.000757	CcSEcCtD
Procainamide—Dizziness—Triamcinolone—rheumatoid arthritis	0.000149	0.000752	CcSEcCtD
Procainamide—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000149	0.00075	CcSEcCtD
Procainamide—Feeling abnormal—Prednisone—rheumatoid arthritis	0.000147	0.00074	CcSEcCtD
Procainamide—Asthenia—Betamethasone—rheumatoid arthritis	0.000147	0.00074	CcSEcCtD
Procainamide—Asthenia—Dexamethasone—rheumatoid arthritis	0.000147	0.00074	CcSEcCtD
Procainamide—Thrombocytopenia—Methotrexate—rheumatoid arthritis	0.000146	0.000735	CcSEcCtD
Procainamide—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.000146	0.000735	CcSEcCtD
Procainamide—Nausea—Prednisolone—rheumatoid arthritis	0.000146	0.000734	CcSEcCtD
Procainamide—Pruritus—Dexamethasone—rheumatoid arthritis	0.000145	0.00073	CcSEcCtD
Procainamide—Pruritus—Betamethasone—rheumatoid arthritis	0.000145	0.00073	CcSEcCtD
Procainamide—Vomiting—Triamcinolone—rheumatoid arthritis	0.000143	0.000723	CcSEcCtD
Procainamide—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000143	0.000721	CcSEcCtD
Procainamide—Nausea—Hydrocortisone—rheumatoid arthritis	0.000142	0.000717	CcSEcCtD
Procainamide—Anorexia—Methotrexate—rheumatoid arthritis	0.000142	0.000716	CcSEcCtD
Procainamide—Urticaria—Prednisone—rheumatoid arthritis	0.000142	0.000714	CcSEcCtD
Procainamide—Abdominal pain—Prednisone—rheumatoid arthritis	0.000141	0.00071	CcSEcCtD
Procainamide—Body temperature increased—Prednisone—rheumatoid arthritis	0.000141	0.00071	CcSEcCtD
Procainamide—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.00014	0.000706	CcSEcCtD
Procainamide—Diarrhoea—Betamethasone—rheumatoid arthritis	0.00014	0.000706	CcSEcCtD
Procainamide—Hypotension—Methotrexate—rheumatoid arthritis	0.000139	0.000702	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	0.000136	0.000684	CcSEcCtD
Procainamide—Dizziness—Dexamethasone—rheumatoid arthritis	0.000135	0.000682	CcSEcCtD
Procainamide—Dizziness—Betamethasone—rheumatoid arthritis	0.000135	0.000682	CcSEcCtD
Procainamide—Nausea—Triamcinolone—rheumatoid arthritis	0.000134	0.000675	CcSEcCtD
Procainamide—Nausea—Methylprednisolone—rheumatoid arthritis	0.000134	0.000674	CcSEcCtD
Procainamide—Hypersensitivity—Prednisone—rheumatoid arthritis	0.000131	0.000662	CcSEcCtD
Procainamide—Vomiting—Dexamethasone—rheumatoid arthritis	0.00013	0.000656	CcSEcCtD
Procainamide—Vomiting—Betamethasone—rheumatoid arthritis	0.00013	0.000656	CcSEcCtD
Procainamide—Decreased appetite—Methotrexate—rheumatoid arthritis	0.000129	0.000653	CcSEcCtD
Procainamide—Asthenia—Prednisone—rheumatoid arthritis	0.000128	0.000645	CcSEcCtD
Procainamide—Pruritus—Prednisone—rheumatoid arthritis	0.000126	0.000636	CcSEcCtD
Procainamide—Feeling abnormal—Methotrexate—rheumatoid arthritis	0.000123	0.000619	CcSEcCtD
Procainamide—Diarrhoea—Prednisone—rheumatoid arthritis	0.000122	0.000615	CcSEcCtD
Procainamide—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.000122	0.000614	CcSEcCtD
Procainamide—Nausea—Betamethasone—rheumatoid arthritis	0.000122	0.000613	CcSEcCtD
Procainamide—Nausea—Dexamethasone—rheumatoid arthritis	0.000122	0.000613	CcSEcCtD
Procainamide—Urticaria—Methotrexate—rheumatoid arthritis	0.000118	0.000597	CcSEcCtD
Procainamide—Dizziness—Prednisone—rheumatoid arthritis	0.000118	0.000594	CcSEcCtD
Procainamide—Abdominal pain—Methotrexate—rheumatoid arthritis	0.000118	0.000594	CcSEcCtD
Procainamide—Body temperature increased—Methotrexate—rheumatoid arthritis	0.000118	0.000594	CcSEcCtD
Procainamide—Vomiting—Prednisone—rheumatoid arthritis	0.000113	0.000571	CcSEcCtD
Procainamide—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.00011	0.000553	CcSEcCtD
Procainamide—Asthenia—Methotrexate—rheumatoid arthritis	0.000107	0.000539	CcSEcCtD
Procainamide—Nausea—Prednisone—rheumatoid arthritis	0.000106	0.000534	CcSEcCtD
Procainamide—Pruritus—Methotrexate—rheumatoid arthritis	0.000105	0.000531	CcSEcCtD
Procainamide—Diarrhoea—Methotrexate—rheumatoid arthritis	0.000102	0.000514	CcSEcCtD
Procainamide—Dizziness—Methotrexate—rheumatoid arthritis	9.85e-05	0.000497	CcSEcCtD
Procainamide—Vomiting—Methotrexate—rheumatoid arthritis	9.47e-05	0.000477	CcSEcCtD
Procainamide—Nausea—Methotrexate—rheumatoid arthritis	8.85e-05	0.000446	CcSEcCtD
Procainamide—SCN2A—Axon guidance—IL6—rheumatoid arthritis	2.82e-05	0.000351	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—NFKB1—rheumatoid arthritis	2.82e-05	0.000351	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL6—rheumatoid arthritis	2.82e-05	0.000351	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CXCL13—rheumatoid arthritis	2.81e-05	0.00035	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—VEGFA—rheumatoid arthritis	2.81e-05	0.000349	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—VEGFA—rheumatoid arthritis	2.81e-05	0.000349	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MED1—rheumatoid arthritis	2.81e-05	0.000349	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TYK2—rheumatoid arthritis	2.79e-05	0.000347	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TGFB1—rheumatoid arthritis	2.78e-05	0.000346	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—VEGFA—rheumatoid arthritis	2.77e-05	0.000344	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	2.75e-05	0.000342	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—IL6—rheumatoid arthritis	2.72e-05	0.000339	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—IL6—rheumatoid arthritis	2.72e-05	0.000339	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—TNF—rheumatoid arthritis	2.72e-05	0.000338	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—IL6—rheumatoid arthritis	2.71e-05	0.000337	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—ALB—rheumatoid arthritis	2.7e-05	0.000336	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL21—rheumatoid arthritis	2.69e-05	0.000334	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SYVN1—rheumatoid arthritis	2.69e-05	0.000334	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—FADS2—rheumatoid arthritis	2.69e-05	0.000334	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TGFB1—rheumatoid arthritis	2.67e-05	0.000333	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TGFB1—rheumatoid arthritis	2.67e-05	0.000333	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PLB1—rheumatoid arthritis	2.66e-05	0.000331	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—IL2RB—rheumatoid arthritis	2.66e-05	0.00033	CbGpPWpGaD
Procainamide—ACHE—Metabolism—BGN—rheumatoid arthritis	2.63e-05	0.000327	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ACP5—rheumatoid arthritis	2.61e-05	0.000324	CbGpPWpGaD
Procainamide—BCHE—Metabolism—B3GNT2—rheumatoid arthritis	2.61e-05	0.000324	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TNF—rheumatoid arthritis	2.6e-05	0.000323	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TGFB1—rheumatoid arthritis	2.58e-05	0.000321	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TGFB1—rheumatoid arthritis	2.58e-05	0.000321	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TAGAP—rheumatoid arthritis	2.58e-05	0.000321	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—C5—rheumatoid arthritis	2.57e-05	0.000319	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—VEGFA—rheumatoid arthritis	2.56e-05	0.000319	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CCL5—rheumatoid arthritis	2.53e-05	0.000314	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ENO1—rheumatoid arthritis	2.51e-05	0.000312	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CX3CR1—rheumatoid arthritis	2.51e-05	0.000312	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MED1—rheumatoid arthritis	2.51e-05	0.000312	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TNF—rheumatoid arthritis	2.5e-05	0.00031	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TNF—rheumatoid arthritis	2.5e-05	0.00031	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALOX5—rheumatoid arthritis	2.42e-05	0.000301	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	2.42e-05	0.000301	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL2RB—rheumatoid arthritis	2.41e-05	0.0003	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CCR6—rheumatoid arthritis	2.41e-05	0.0003	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TNF—rheumatoid arthritis	2.41e-05	0.000299	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TNF—rheumatoid arthritis	2.41e-05	0.000299	CbGpPWpGaD
Procainamide—BCHE—Metabolism—BGN—rheumatoid arthritis	2.35e-05	0.000292	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	2.35e-05	0.000292	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	2.34e-05	0.000291	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MED1—rheumatoid arthritis	2.34e-05	0.000291	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—rheumatoid arthritis	2.34e-05	0.00029	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—C5—rheumatoid arthritis	2.33e-05	0.00029	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—B3GNT2—rheumatoid arthritis	2.33e-05	0.00029	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ACP5—rheumatoid arthritis	2.33e-05	0.00029	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—rheumatoid arthritis	2.28e-05	0.000284	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—POMC—rheumatoid arthritis	2.28e-05	0.000283	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CCR5—rheumatoid arthritis	2.28e-05	0.000283	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—CXCL8—rheumatoid arthritis	2.27e-05	0.000283	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—C3—rheumatoid arthritis	2.22e-05	0.000277	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—MMP1—rheumatoid arthritis	2.22e-05	0.000276	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CXCL2—rheumatoid arthritis	2.21e-05	0.000274	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—MMP9—rheumatoid arthritis	2.2e-05	0.000273	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—TNF—rheumatoid arthritis	2.19e-05	0.000273	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—IL6—rheumatoid arthritis	2.19e-05	0.000273	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCR6—rheumatoid arthritis	2.19e-05	0.000272	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—NFKB1—rheumatoid arthritis	2.18e-05	0.000271	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—B3GNT2—rheumatoid arthritis	2.17e-05	0.00027	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ACP5—rheumatoid arthritis	2.17e-05	0.00027	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALOX5—rheumatoid arthritis	2.16e-05	0.000269	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—SAA1—rheumatoid arthritis	2.16e-05	0.000268	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—LEP—rheumatoid arthritis	2.14e-05	0.000267	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PDE2A—rheumatoid arthritis	2.14e-05	0.000266	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.13e-05	0.000265	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—BGN—rheumatoid arthritis	2.1e-05	0.000261	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—IL6—rheumatoid arthritis	2.1e-05	0.000261	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PLB1—rheumatoid arthritis	2.04e-05	0.000253	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—IL6—rheumatoid arthritis	2.01e-05	0.000251	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—IL6—rheumatoid arthritis	2.01e-05	0.000251	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CXCL2—rheumatoid arthritis	2e-05	0.000249	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCL3—rheumatoid arthritis	2e-05	0.000249	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—MMP1—rheumatoid arthritis	1.98e-05	0.000246	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ENO1—rheumatoid arthritis	1.98e-05	0.000246	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—VEGFA—rheumatoid arthritis	1.97e-05	0.000246	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—SAA1—rheumatoid arthritis	1.96e-05	0.000244	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—BGN—rheumatoid arthritis	1.96e-05	0.000243	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.94e-05	0.000242	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—IL6—rheumatoid arthritis	1.94e-05	0.000242	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—IL6—rheumatoid arthritis	1.94e-05	0.000242	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALOX5—rheumatoid arthritis	1.93e-05	0.00024	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—IL6—rheumatoid arthritis	1.91e-05	0.000238	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—LEP—rheumatoid arthritis	1.91e-05	0.000238	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.9e-05	0.000236	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RBPJ—rheumatoid arthritis	1.88e-05	0.000234	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CXCL12—rheumatoid arthritis	1.88e-05	0.000233	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—BDKRB2—rheumatoid arthritis	1.88e-05	0.000233	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—ADRBK1—rheumatoid arthritis	1.86e-05	0.000231	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—POMC—rheumatoid arthritis	1.84e-05	0.000229	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TGFB1—rheumatoid arthritis	1.81e-05	0.000225	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—rheumatoid arthritis	1.81e-05	0.000225	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CAT—rheumatoid arthritis	1.81e-05	0.000225	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—CCL2—rheumatoid arthritis	1.8e-05	0.000224	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALOX5—rheumatoid arthritis	1.8e-05	0.000224	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PLD4—rheumatoid arthritis	1.79e-05	0.000223	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—POMC—rheumatoid arthritis	1.78e-05	0.000221	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL6—rheumatoid arthritis	1.77e-05	0.00022	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ENO1—rheumatoid arthritis	1.76e-05	0.000219	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	1.75e-05	0.000218	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CCL2—rheumatoid arthritis	1.74e-05	0.000216	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.73e-05	0.000216	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ACAN—rheumatoid arthritis	1.73e-05	0.000215	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—MMP2—rheumatoid arthritis	1.71e-05	0.000213	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	1.71e-05	0.000213	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—BDKRB2—rheumatoid arthritis	1.7e-05	0.000212	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CXCL12—rheumatoid arthritis	1.7e-05	0.000212	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.7e-05	0.000211	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TNF—rheumatoid arthritis	1.69e-05	0.00021	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—ADRBK1—rheumatoid arthritis	1.68e-05	0.00021	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL13—rheumatoid arthritis	1.66e-05	0.000207	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CXCL10—rheumatoid arthritis	1.66e-05	0.000206	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—POMC—rheumatoid arthritis	1.64e-05	0.000204	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC25A12—rheumatoid arthritis	1.63e-05	0.000202	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CCL2—rheumatoid arthritis	1.61e-05	0.0002	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—RASGRP1—rheumatoid arthritis	1.59e-05	0.000198	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGES—rheumatoid arthritis	1.58e-05	0.000197	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GC—rheumatoid arthritis	1.58e-05	0.000197	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ENO1—rheumatoid arthritis	1.57e-05	0.000196	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PRKCQ—rheumatoid arthritis	1.55e-05	0.000193	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—MMP2—rheumatoid arthritis	1.53e-05	0.00019	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.52e-05	0.000189	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—MTHFR—rheumatoid arthritis	1.51e-05	0.000187	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CXCL10—rheumatoid arthritis	1.51e-05	0.000187	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TLE3—rheumatoid arthritis	1.5e-05	0.000186	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IRAK1—rheumatoid arthritis	1.5e-05	0.000186	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CX3CR1—rheumatoid arthritis	1.48e-05	0.000184	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	1.47e-05	0.000183	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PLB1—rheumatoid arthritis	1.47e-05	0.000183	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ENO1—rheumatoid arthritis	1.47e-05	0.000182	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CCL5—rheumatoid arthritis	1.43e-05	0.000178	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL2RB—rheumatoid arthritis	1.43e-05	0.000177	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—CXCL8—rheumatoid arthritis	1.42e-05	0.000177	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CAT—rheumatoid arthritis	1.42e-05	0.000177	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CSF2—rheumatoid arthritis	1.41e-05	0.000175	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—C5—rheumatoid arthritis	1.38e-05	0.000171	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CXCL8—rheumatoid arthritis	1.38e-05	0.000171	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—MMP3—rheumatoid arthritis	1.37e-05	0.000171	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	1.37e-05	0.000171	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—IL6—rheumatoid arthritis	1.37e-05	0.00017	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NFATC1—rheumatoid arthritis	1.35e-05	0.000168	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCL5—rheumatoid arthritis	1.3e-05	0.000161	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCR6—rheumatoid arthritis	1.29e-05	0.000161	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MED1—rheumatoid arthritis	1.29e-05	0.00016	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CCR5—rheumatoid arthritis	1.29e-05	0.00016	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CSF2—rheumatoid arthritis	1.28e-05	0.000159	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CXCL8—rheumatoid arthritis	1.27e-05	0.000158	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CAT—rheumatoid arthritis	1.27e-05	0.000158	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—IL2RA—rheumatoid arthritis	1.27e-05	0.000158	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NCF2—rheumatoid arthritis	1.26e-05	0.000157	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—C3—rheumatoid arthritis	1.26e-05	0.000156	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SH2B3—rheumatoid arthritis	1.23e-05	0.000153	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TRAF6—rheumatoid arthritis	1.23e-05	0.000153	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GZMB—rheumatoid arthritis	1.22e-05	0.000152	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—POMC—rheumatoid arthritis	1.21e-05	0.00015	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ACP5—rheumatoid arthritis	1.2e-05	0.000149	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—B3GNT2—rheumatoid arthritis	1.2e-05	0.000149	CbGpPWpGaD
Procainamide—ACHE—Metabolism—MTHFR—rheumatoid arthritis	1.19e-05	0.000148	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL3—rheumatoid arthritis	1.18e-05	0.000147	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL2—rheumatoid arthritis	1.18e-05	0.000147	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCR5—rheumatoid arthritis	1.17e-05	0.000145	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SAA1—rheumatoid arthritis	1.16e-05	0.000144	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL2RA—rheumatoid arthritis	1.15e-05	0.000143	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—C3—rheumatoid arthritis	1.14e-05	0.000142	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NCF1—rheumatoid arthritis	1.13e-05	0.000141	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CAT—rheumatoid arthritis	1.13e-05	0.000141	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ALB—rheumatoid arthritis	1.1e-05	0.000137	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CD28—rheumatoid arthritis	1.09e-05	0.000136	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—BGN—rheumatoid arthritis	1.08e-05	0.000134	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MTHFR—rheumatoid arthritis	1.06e-05	0.000132	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CAT—rheumatoid arthritis	1.06e-05	0.000131	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—NOS3—rheumatoid arthritis	1.05e-05	0.000131	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—UBE2D1—rheumatoid arthritis	1.03e-05	0.000128	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL12—rheumatoid arthritis	1.01e-05	0.000125	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—BDKRB2—rheumatoid arthritis	1.01e-05	0.000125	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—POMC—rheumatoid arthritis	1e-05	0.000125	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6ST—rheumatoid arthritis	9.98e-06	0.000124	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADRBK1—rheumatoid arthritis	9.95e-06	0.000124	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALOX5—rheumatoid arthritis	9.94e-06	0.000124	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTGS2—rheumatoid arthritis	9.62e-06	0.00012	CbGpPWpGaD
Procainamide—ACHE—Metabolism—POMC—rheumatoid arthritis	9.49e-06	0.000118	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MTHFR—rheumatoid arthritis	9.45e-06	0.000118	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RASGRP1—rheumatoid arthritis	9.39e-06	0.000117	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SYK—rheumatoid arthritis	9.36e-06	0.000116	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PRKCQ—rheumatoid arthritis	9.18e-06	0.000114	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—POMC—rheumatoid arthritis	9.13e-06	0.000114	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—STAT1—rheumatoid arthritis	9.02e-06	0.000112	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCL2—rheumatoid arthritis	8.93e-06	0.000111	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6R—rheumatoid arthritis	8.9e-06	0.000111	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL10—rheumatoid arthritis	8.89e-06	0.000111	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MTHFR—rheumatoid arthritis	8.81e-06	0.00011	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALB—rheumatoid arthritis	8.65e-06	0.000108	CbGpPWpGaD
Procainamide—BCHE—Metabolism—POMC—rheumatoid arthritis	8.47e-06	0.000105	CbGpPWpGaD
Procainamide—ACHE—Metabolism—NOS3—rheumatoid arthritis	8.28e-06	0.000103	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MMP3—rheumatoid arthritis	8.11e-06	0.000101	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—TYK2—rheumatoid arthritis	8.11e-06	0.000101	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	8.1e-06	0.000101	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PTK2—rheumatoid arthritis	7.81e-06	9.71e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CXCL8—rheumatoid arthritis	7.77e-06	9.67e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALB—rheumatoid arthritis	7.72e-06	9.6e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL5—rheumatoid arthritis	7.66e-06	9.52e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTGS2—rheumatoid arthritis	7.57e-06	9.41e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—POMC—rheumatoid arthritis	7.56e-06	9.4e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CSF2—rheumatoid arthritis	7.54e-06	9.38e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—IL2—rheumatoid arthritis	7.43e-06	9.24e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NOS3—rheumatoid arthritis	7.38e-06	9.18e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SPP1—rheumatoid arthritis	7.09e-06	8.82e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CXCL8—rheumatoid arthritis	7.06e-06	8.78e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—POMC—rheumatoid arthritis	7.05e-06	8.77e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCR5—rheumatoid arthritis	6.9e-06	8.58e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALB—rheumatoid arthritis	6.89e-06	8.57e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL2RA—rheumatoid arthritis	6.8e-06	8.46e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTGS2—rheumatoid arthritis	6.75e-06	8.4e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL2—rheumatoid arthritis	6.75e-06	8.39e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—C3—rheumatoid arthritis	6.74e-06	8.38e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NOS3—rheumatoid arthritis	6.59e-06	8.2e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALB—rheumatoid arthritis	6.43e-06	7.99e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LEP—rheumatoid arthritis	6.28e-06	7.8e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NOS3—rheumatoid arthritis	6.15e-06	7.64e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTGS2—rheumatoid arthritis	6.03e-06	7.5e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FN1—rheumatoid arthritis	5.92e-06	7.36e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6ST—rheumatoid arthritis	5.89e-06	7.33e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CAT—rheumatoid arthritis	5.83e-06	7.25e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CD80—rheumatoid arthritis	5.67e-06	7.06e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTGS2—rheumatoid arthritis	5.62e-06	6.99e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—POMC—rheumatoid arthritis	5.39e-06	6.7e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL2—rheumatoid arthritis	5.27e-06	6.56e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6R—rheumatoid arthritis	5.26e-06	6.54e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	4.87e-06	6.05e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TYK2—rheumatoid arthritis	4.79e-06	5.96e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOS3—rheumatoid arthritis	4.7e-06	5.85e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL8—rheumatoid arthritis	4.17e-06	5.19e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL2—rheumatoid arthritis	3.99e-06	4.96e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6—rheumatoid arthritis	3.97e-06	4.93e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—POMC—rheumatoid arthritis	3.89e-06	4.84e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MMP9—rheumatoid arthritis	3.77e-06	4.69e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NFKB1—rheumatoid arthritis	3.73e-06	4.64e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MAPK8—rheumatoid arthritis	3.67e-06	4.56e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALB—rheumatoid arthritis	3.55e-06	4.41e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	3.39e-06	4.22e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VEGFA—rheumatoid arthritis	3.39e-06	4.21e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TGFB1—rheumatoid arthritis	3.11e-06	3.87e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	3.1e-06	3.86e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TP53—rheumatoid arthritis	2.56e-06	3.18e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6—rheumatoid arthritis	2.34e-06	2.91e-05	CbGpPWpGaD
